青年乙肝血清学阴性者复种所需的乙型肝炎疫苗剂量
该回顾性队列研究纳入2012至2015年入学时乙肝三项血清标志物均阴性的研究生1037人,按意愿接受0至3剂乙肝疫苗加强免疫,入学时检测抗-HBs。结果显示,接种0、1、2、3剂者的抗-HBs阳性率分别为17.7%、52.1%、78.6%和90.9%;对大学时抗-HBs滴度极低者(<3 mIU/ml)接种两剂、滴度很低者(3-10 mIU/ml)接种一剂,阳性率可达95%。
要点
- 青年乙肝血清学阴性者复种0至3剂的抗-HBs阳性率分别为17.7%、52.1%、78.6%和90.9%。
- 大学时抗-HBs<3 mIU/ml者复种两剂后阳性率可达95%。
- 大学时抗-HBs 3-10 mIU/ml者复种一剂后阳性率可达95%。
核心结论
- 对大学时抗-HBs滴度极低(<3 mIU/ml)的青年接种两剂乙肝加强疫苗、对滴度很低(3-10 mIU/ml)者接种一剂,可使抗-HBs阳性率达到至少95%。
研究设计与样本
- 回顾性队列研究,纳入2012至2015年大学入学时乙肝三项血清标志物均阴性的研究生1037人,按意愿接受0至3剂乙肝疫苗加强免疫。
主要发现
- 接种0、1、2、3剂乙肝加强疫苗者的抗-HBs阳性率分别为17.7%、52.1%、78.6%和90.9%。
- 接种一剂后抗-HBs滴度极低者及接种两剂后滴度极低者,在3 mIU/ml界值时阳性率达到95%。
关键数值与推荐
- 大学时抗-HBs<3 mIU/ml的青年需接种两剂乙肝加强疫苗以达到至少95%阳性率。
- 大学时抗-HBs 3-10 mIU/ml的青年接种一剂乙肝加强疫苗即可达到至少95%阳性率。
临床怎么用
- 对大学入学时乙肝三项血清标志物均阴性的青年,可依据其抗-HBs滴度分层:<3 mIU/ml者建议两剂加强、3-10 mIU/ml者建议一剂加强。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: To determine the required hepatitis B vaccine doses for subjects who were seronegative for three hepatitis B seromarkers during their youth who wish to have seroprotective antibodies against the hepatitis B surface antigen (anti-HBs). METHODS: We conducted a retrospective cohort study. From 2012 to 2015, graduate school students born after 1986 who were seronegative for three hepatitis B virus seromarkers at college entrance (n = 1037) were recruited. Four groups of subjects received zero to three doses of a hepatitis B vaccine booster at their free willingness, and their anti-HBs titre were measured at their graduate school entrance. Very low and extremely low antibody titres against the hepatitis B surface antigen were elucidated by graphic inference to determine the required booster dose cut-off value for seropositivity after revaccination. RESULTS: The anti-HBs seropositive rates in the four groups of subjects receiving the hepatitis B booster vaccine(s) were 17.7%, 52.1%, 78.6% and 90.9% for those receiving zero, one, two and three doses, respectively. In subjects with very low antibody titres against the hepatitis B surface antigen after one dose of the vaccine booster and subjects with an extremely low titre after two doses of the booster, the seropositive rates reached 95% at the cut-off value of 3 mIU/ml. CONCLUSION: A seropositive rate of at least 95% can be reached by the administration of two hepatitis B booster doses to youths with extremely low antibody titres against the hepatitis B surface antigen (<3 mIU/ml) and administering one dose to those with very low titres (3-10 mIU/ml) at college.
引用
- Jan CF, Liu TH, Ho CH, et al. Doses of hepatitis B revaccination needed for the seronegative youths to be seropositive to antibody against hepatitis B surface antigen. Fam Pract. 2020. PMID: 31375819. doi:10.1093/fampra/cmz039
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。